Stocks / NASDAQ / Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc.

Our Opinion

Immune Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“In preclinical animal tumor models, combination therapy has demonstrated synergistic activity with cytotoxic drugs as well as anti-angiogenic drugs, such as Avastin.” Read the following article

Company Description

Immune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of targeted therapeutics, including mAbs nanotherapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. The company acquires, develops and commercialises prescription drug products. Immune Pharmaceuticals was founded by Daniel G. Teper and Jean Elie Kadouche in March, 1993 and is headquartered in New York, NY. [Source: MarketWatch]

Company Website: